Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05663463 · ClinicalTrials.gov registry record · NA
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
A NA study of Solid Organ Transplant, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 74
- Enrollment target
- 1
- Study location
NCT05663463 is a NA study of Solid Organ Transplant that has completed, run by University of Minnesota. The registered enrollment target is 74 participants, below the 615-participant average among 4 other Solid Organ Transplant trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05663463, a NA study of Solid Organ Transplant, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 74 participants
- Enrollment target
- 1
- Study location
Study Summary
In solid organ transplant (SOT) the receipt of influenza vaccine in an influenza season is associated with decreased disease severity as demonstrated by the presence of pneumonia and ICU admissions. Different strategies have been assessed to optimize vaccine efficacy and immunogenicity of the influenza vaccine in the solid organ transplant recipient (SOTR). The primary objective of the study is to evaluate the immunogenicity of 2 doses of the high dose influenza vaccine utilizing neutralizing antibody assays. A control group receiving 1 HD influenza vaccine will be included.
Conditions Studied
Interventions
- DRUG Fluzone High-Dose - 2 doses
- DRUG Fluzone High-Dose - 1 dose of HD
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 74 participants |
| Start Date | 2023-09-11 |
| Est. Completion | 2025-06-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05663463
The ClinicalTrials.gov registry entry for NCT05663463 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 74 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 615-participant average among 4 other Solid Organ Transplant trials with a reported enrollment target (88% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Solid Organ Transplant appearing as the primary indexed condition, and to 2 interventions - of which Fluzone High-Dose - 2 doses is the first listed.
NCT05663463 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05663463 about?
NCT05663463 is a clinical study titled "Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients". In solid organ transplant (SOT) the receipt of influenza vaccine in an influenza season is associated with decreased disease severity as demonstrated by the presence of pneumonia and ICU admissions. Different strategies have been assessed to optimize vaccine efficacy and immunogenicity of the influe...
What is the current status of trial NCT05663463?
This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2023-09-11. Estimated completion is 2025-06-16.
What conditions does trial NCT05663463 study?
This clinical trial studies the following conditions: Solid Organ Transplant.
What interventions are being tested in trial NCT05663463?
The interventions under investigation include: Fluzone High-Dose - 2 doses (DRUG), Fluzone High-Dose - 1 dose of HD (DRUG).
Who is sponsoring clinical trial NCT05663463?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05663463 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Solid Organ Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
RECRUITING
-
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
ACTIVE NOT RECRUITING
-
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
ACTIVE NOT RECRUITING · Phase 2
-
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
ACTIVE NOT RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.